等待開盤 11-26 09:30:00 美东时间
+2.360
+2.28%
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从6美元升至8美元;HC Wainwright & Co.:维持MediWound"买入"评级,目标价从31美元升至36美元
11-24 11:23
Baird analyst Andrew Wittmann maintains Construction Partners (NASDAQ:ROAD) with a Outperform and lowers the price target from $131 to $124.
11-21 22:21
Construction Partners shares are trading lower after the company reported mixed...
11-20 21:51
Construction Partners press release (ROAD): Q4 GAAP EPS of $1.02 misses by $0.08. Revenue of $899.85M (+67.2% Y/Y) in-line. Project backlog was approximately $3.03 billion at September 30, 2025, compa...
11-20 20:26
Construction Partners (NASDAQ:ROAD) affirms FY2026 sales outlook from $3.400 billion-$3.500 billion to $3.400 billion-$3.500 billion vs $2.805 billion estimate.
11-20 20:19
Construction Partners (NASDAQ:ROAD) reported quarterly earnings of $1.02 per share which missed the analyst consensus estimate of $1.09 by 6.85 percent. This is a 82.14 percent increase over earnings of $0.56 per share
11-20 20:16
Companies Reporting Before The Bell • Atkore (NYSE:ATKR) is likely to report qu...
11-20 19:11
Construction Partners (NASDAQ:ROAD) is set to give its latest quarterly earning...
11-19 23:02
Roadzen Inc. will acquire a commercial auto insurance broker and MGU operating across the U.S., boosting its expansion in the $75-80 billion U.S. commercial auto insurance market. The acquisition, expected to close this quarter, is non-dilutive for shareholders and will generate over $30 million in annual premiums and $8 million in annual revenues. Roadzen aims to leverage the platform to integrate with its AI-powered solutions, targeting $150 mi...
10-29 11:30
今日重点评级关注:摩根士丹利:维持Viking Therapeutics"超配"评级,目标价从98美元升至102美元;摩根大通:维持IDEAYA Biosciences"超配"评级,目标价从74美元升至79美元
10-24 09:51